A Case Report of Consecutive Live Birth Twice Through in vitro Fertilization and Embryo Transfer After Endometrial Carcinoma Fertility Preservation Treatment
Jingying Wang,Ying Fang,Tong Chen,Zhimin Xin,Yumei Wu,Xiaokui Yang
DOI: https://doi.org/10.2147/ijwh.s441984
2024-03-07
International Journal of Women s Health
Abstract:Jingying Wang, 1, 2 Ying Fang, 1, 2 Tong Chen, 1, 2 Zhimin Xin, 1, 2 Yumei Wu, 3, 4, &ast Xiaokui Yang 1, 2, &ast 1 Department of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Department of Human Reproductive Medicine, Beijing Maternal and Child Health Care Hospital, Beijing, People's Republic of China; 3 Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, People's Republic of China; 4 Department of Gynecological Oncology, Beijing Maternal and Child Health Care Hospital, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaokui Yang, Department of Human Reproductive Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, 251 Yaojiayuan Road, Beijing, 100026, People's Republic of China, Tel +86 522 766 15, Email Yumei Wu, Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, 251 Yaojiayuan Road, Beijing, 100026, People's Republic of China, Tel +86 522 766 53, Email Preserving fertility is a vital concern for young women diagnosed with endometrial carcinoma. The clinical management of such patients is often disappointing. It is rare to have two consecutive successful pregnancies. We present a child-bearing-age woman who underwent fertility preservation therapy due to endometrial carcinoma. Following fertility preservation therapy, she underwent in vitro fertilization and embryo transfer. After receiving her first fresh embryo transfer, she successfully conceived and gave birth to a healthy child. Two years after the first embryo transfer and regular follow-up, she had another frozen embryo transfer of two cleavage embryos and successfully gave birth to another healthy baby. After the delivery of her second child, she underwent surgical treatment for endometrial carcinoma. For endometrial carcinoma patients who intend to preserve fertility, high-quality long-term follow-up and personalized treatment are necessary. Plain Language Summary: In this case report, we share the story of one young woman who had endometrial cancer but desired to have children. She received fertility-sparing treatment and in vitro fertilization to increase her chances of conceiving. She successfully delivered a healthy child after the first embryo transfer. Two years later, she had another healthy child through a second frozen embryo transfer. Rigorous monitoring showed no cancer recurrence throughout the entire treatment. There are currently few reported cases of a patient with endometrial cancer successfully and safely giving birth twice through assisted reproductive technology. This case report emphasizes that, with personalized treatment and monitoring, endometrial cancer patients can have multiple pregnancies safely. In summary, this case report brings hope to young women with early-stage endometrial cancer who aspire to become mothers. With the right support, they can overcome the challenges of cancer and have their own babies. Keywords: endometrial carcinoma, fertility preservation, pregnancy outcome, in vitro fertilization-embryo transfer Endometrial carcinoma (EC) is a malignancy that originates from the endometrium, ranking as the fifth most prevalent cancer in females. 1 The standard treatment for EC is surgery, which includes total extra-fascial hysterectomy, bilateral salpingo-oophorectomy, and pelvic and para-aortic lymph node dissection. 2 Patients with early-stage EC can usually achieve satisfactory survival outcomes after surgery. The 5-year survival rate for these patients is up to 96%. 3 Approximately 14–25% of EC patients are premenopausal, and 4–7% of them are under 40 years of age. 4,5 These patients often express a strong desire for fertility preservation. Fortunately, patients diagnosed with early-stage and well-differentiated EC usually have a favorable prognosis. However, for women of childbearing age who wish to preserve their fertility, this definitive approach may not be an optimal option. Previous studies have explored the safety and feasibility of hormonal therapy to preserve fertility in early-stage EC women. 6,7 Hormonal therapy includes medroxyprogesterone acetate (MPA), levonorgestrel-releasing intrauterine devices (LNG-IUDs) and more recently, gonadotropin-releasing hormone agonist (GnRH-a). 8,9 Hysteroscopic pathological examination is recommended to determine the effectiveness of the medication or the progressing dise -Abstract Truncated-
obstetrics & gynecology